Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(10)
•••
Post by jimmyjongon Jun 20, 2016 4:31pm
325 Views
Post# 24981338

RBC Capital Reaffirms “Outperform” Rating for Concordia

RBC Capital Reaffirms “Outperform” Rating for Concordia Concordia Healthcare Corp (TSE:CXR)‘s stock had its “outperform” rating reissued by stock analysts at RBC Capital in a research report issued to clients and investors on Monday, StockTargetPrices.com reports. They currently have a C$73.00 price target on the stock. RBC Capital’s price target points to a potential upside of 151.72% from the stock’s current price.

https://www.com-unik.info/rbc-capital-reaffirms-outperform-rating-for-concordia-healthcare-corp-cxr/
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities